These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 39174104)

  • 1. Absorption enhancement strategies in chitosan-based nanosystems and hydrogels intended for ocular delivery: Latest advances for optimization of drug permeation.
    Dmour I
    Carbohydr Polym; 2024 Nov; 343():122486. PubMed ID: 39174104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Pontillo ARN; Detsi A
    Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid in ocular drug delivery.
    Zhang X; Wei D; Xu Y; Zhu Q
    Carbohydr Polym; 2021 Jul; 264():118006. PubMed ID: 33910737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Chitosan-Based Nanoparticles for Drug Delivery.
    Mikušová V; Mikuš P
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
    Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
    Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New nanoparticles for topical ocular delivery of erythropoietin.
    Silva B; Marto J; Braz BS; Delgado E; Almeida AJ; Gonçalves L
    Int J Pharm; 2020 Feb; 576():119020. PubMed ID: 31935477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
    Deng F; Hu W; Chen H; Tang Y; Zhang L
    Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.
    Taheriazam A; Entezari M; Firouz ZM; Hajimazdarany S; Hossein Heydargoy M; Amin Moghadassi AH; Moghadaci A; Sadrani A; Motahhary M; Harif Nashtifani A; Zabolian A; Tabari T; Hashemi M; Raesi R; Jiang M; Zhang X; Salimimoghadam S; Ertas YN; Sun D
    Environ Res; 2023 Jul; 228():115912. PubMed ID: 37068723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems.
    Peters MCC; Santos Neto ED; Monteiro LM; Yukuyama MN; Machado MGM; de Oliveira IF; Zanin MHA; Löbenberg R; Bou-Chacra N
    J Drug Target; 2020 Mar; 28(3):259-270. PubMed ID: 31491352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Stimuli-Responsive Chitosan Hydrogels for Drug Delivery Systems.
    Xia Y; Ma Z; Wu X; Wei H; Zhang H; Li G; Qian Y; Shahriari-Khalaji M; Hou K; Cao R; Zhu M
    Macromol Biosci; 2024 May; 24(5):e2300399. PubMed ID: 38011585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
    Chaiyasan W; Srinivas SP; Tiyaboonchai W
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.